Zheng Quan Shi Bao Wang·2025-11-14 09:28Market Overview - The Shanghai Composite Index fell by 0.97% on November 14, with only 4 out of the 28 sectors rising, led by the comprehensive and real estate sectors, which increased by 1.58% and 0.39% respectively [2] - The pharmaceutical and biological industry saw a slight increase of 0.17% [2] Capital Flow Analysis - The main capital outflow from the two markets totaled 81.32 billion yuan, with 5 sectors experiencing net inflows [2] - The pharmaceutical and biological sector had the highest net inflow of 680 million yuan, while the defense and military industry followed with a net inflow of 667 million yuan despite a decline of 0.44% [2] Pharmaceutical Sector Performance - Within the pharmaceutical and biological sector, 283 out of 477 stocks rose, with 15 hitting the daily limit [3] - The top three stocks with the highest net inflow were: - Zhongsheng Pharmaceutical with a net inflow of 732 million yuan - Haichen Pharmaceutical and Te Yi Pharmaceutical, both with net inflows of 299 million yuan [3] Capital Inflow and Outflow Rankings - The top stocks in terms of capital inflow included: - Zhongsheng Pharmaceutical: +9.98%, turnover rate 10.39%, inflow 731.86 million yuan - Haichen Pharmaceutical: +19.99%, turnover rate 26.19%, inflow 298.70 million yuan - Te Yi Pharmaceutical: +9.98%, turnover rate 44.11%, inflow 298.50 million yuan [4] - The stocks with the highest capital outflow included: - Fuxiang Pharmaceutical: -7.77%, turnover rate 42.68%, outflow -532.38 million yuan - Hefeng China: -7.69%, turnover rate 28.48%, outflow -338.09 million yuan - Renmin Tongtai: -10.04%, turnover rate 7.37%, outflow -125.52 million yuan [5]